Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function. In Vivo: Valbenazine shows a distinctive improvement in tardive dyskinesia symptoms during the successful Phase II trial[1].

Price Not Available 25mg Valbenazine Supplier Page
Trivial name Valbenazine
Catalog Number HY-16771
Alternative Name(s) NBI-98854
Research Area Neurological Disease
CAS# 1025504-45-3
Purity ≥98%
Size 25mg
Supplier Page